Kribben A - Search Results

1

Randomized, open-label, comparative phase IV study on the bioavailability of Ciclosporin Pro (Teva) versus Sandimmun® Optoral (Novartis) under fasting versus fed conditions in patients with stable renal transplants.

Gäckler A, Dolff S, Rohn H, Korth J, Wilde B, Eisenberger U, Mitchell A, Kribben A, Witzke O. Gäckler A, et al. Among authors: kribben a. BMC Nephrol. 2019 May 14;20(1):167. doi: 10.1186/s12882-019-1340-z. BMC Nephrol. 2019. PMID: 31088392 Free PMC article. Clinical Trial.

2

Interleukin-2 given to asymptomatic HIV-infected individuals leads to an exaggerated response of the pituitary gland to the action of CRH.

Witzke O, Winterhagen T, Kribben A, Philipp T, Mann K, Reinhardt W. Witzke O, et al. Among authors: kribben a. Clin Endocrinol (Oxf). 2003 Jul;59(1):104-9. doi: 10.1046/j.1365-2265.2003.01803.x. Clin Endocrinol (Oxf). 2003. PMID: 12807511

3

A patient without monocytes who had pulmonary renal syndrome.

Witzke O, Patschan D, Dürig J, Lindemann M, Wenzel RR, Philipp T, Grosse-Wilde H, Kribben A. Witzke O, et al. Among authors: kribben a. Am J Kidney Dis. 2004 Sep;44(3):556-8. Am J Kidney Dis. 2004. PMID: 15332229

4

Serum C3 complement concentrations correlate with liver function in patients with liver cirrhosis.

Baumann M, Witzke O, Canbay A, Patschan S, Treichel U, Gerken G, Philipp T, Kribben A. Baumann M, et al. Among authors: kribben a. Hepatogastroenterology. 2004 Sep-Oct;51(59):1451-3. Hepatogastroenterology. 2004. PMID: 15362774

5

Which patients benefit from hemodialysis therapy in hepatorenal syndrome?

Witzke O, Baumann M, Patschan D, Patschan S, Mitchell A, Treichel U, Gerken G, Philipp T, Kribben A. Witzke O, et al. Among authors: kribben a. J Gastroenterol Hepatol. 2004 Dec;19(12):1369-73. doi: 10.1111/j.1440-1746.2004.03471.x. J Gastroenterol Hepatol. 2004. PMID: 15610310

6

Rosiglitazone is a safe and effective treatment option of new-onset diabetes mellitus after renal transplantation.

Pietruck F, Kribben A, Van TN, Patschan D, Herget-Rosenthal S, Janssen O, Mann K, Philipp T, Witzke O. Pietruck F, et al. Among authors: kribben a. Transpl Int. 2005 Apr;18(4):483-6. doi: 10.1111/j.1432-2277.2004.00076.x. Transpl Int. 2005. PMID: 15773972 Free article. Clinical Trial.

7

OKT3 therapy in addition to tacrolimus is associated with improved long-term function in patients with steroid refractory renal allograft rejection.

Patschan D, Kribben A, Pietruck F, Lutz J, Binek M, Philipp T, Heemann U, Witzke O. Patschan D, et al. Among authors: kribben a. Nephron Clin Pract. 2006;103(3):c94-9. doi: 10.1159/000092017. Epub 2006 Mar 13. Nephron Clin Pract. 2006. PMID: 16534238 Clinical Trial.

8

CCL19-IgG prevents allograft rejection by impairment of immune cell trafficking.

Ziegler E, Gueler F, Rong S, Mengel M, Witzke O, Kribben A, Haller H, Kunzendorf U, Krautwald S. Ziegler E, et al. Among authors: kribben a. J Am Soc Nephrol. 2006 Sep;17(9):2521-32. doi: 10.1681/ASN.2005070782. Epub 2006 Aug 9. J Am Soc Nephrol. 2006. PMID: 16899521

9

Novel technique for blood circuit reconstruction in mouse heart transplantation model.

Wu K, Zhang J, Fu J, Wu S, Philipp T, Uwe H, Kribben A, Witzke O. Wu K, et al. Among authors: kribben a. Microsurgery. 2006;26(8):594-8. doi: 10.1002/micr.20293. Microsurgery. 2006. PMID: 17066407

10

[Hepatorenal syndrome. What's new in 2007?].

Witzke O, Gerken G, Kribben A, Philipp T. Witzke O, et al. Among authors: kribben a. Med Klin (Munich). 2007 Mar 15;102(3):203-8. doi: 10.1007/s00063-007-1024-5. Med Klin (Munich). 2007. PMID: 17345016 German.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

317 results

Search Page

Filters